Cogent Biosciences Inc [COGT] stock prices are up 2.43% to $7.17 at the moment. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The COGT shares have gain 2.58% over the last week, with a monthly amount drifted -22.99%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Cogent Biosciences Inc [NASDAQ: COGT] stock has seen the most recent analyst activity on December 11, 2024, when Needham downgraded its rating to a Hold. Previously, Robert W. Baird downgraded its rating to Neutral on February 26, 2024, and dropped its price target to $8. On February 08, 2024, Citigroup initiated with a Buy rating and assigned a price target of $11 on the stock. Wedbush downgraded its rating to a Neutral but stick to its price target of $5 on December 11, 2023. JP Morgan initiated its recommendation with a Overweight and recommended $18 as its price target on December 08, 2023. Robert W. Baird started tracking with a Outperform rating for this stock on April 28, 2023, and assigned it a price target of $20.
The stock price of Cogent Biosciences Inc [COGT] has been fluctuating between $5.73 and $12.61 over the past year. Currently, Wall Street analysts expect the stock to reach $14.5 within the next 12 months. Cogent Biosciences Inc [NASDAQ: COGT] shares were valued at $7.17 at the most recent close of the market. An investor can expect a potential return of 102.23% based on the average COGT price forecast.
Analyzing the COGT fundamentals
To continue investigating profitability, this company’s Return on Assets is posted at -0.78, Equity is -0.75 and Total Capital is -1.01. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.07.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 6.88 points at the first support level, and at 6.58 for the second support level. However, for the 1st resistance point, the stock is sitting at 7.37, and for the 2nd resistance point, it is at 7.57.
Ratios To Look Out For
It’s worth pointing out that Cogent Biosciences Inc [NASDAQ:COGT]’s Current Ratio is 5.32. Further, the Quick Ratio stands at 5.32, while the Cash Ratio is 1.76.
Transactions by insiders
Recent insider trading involved Pinnow Cole, Chief Commercial Officer, that happened on Jan 14 ’25 when 43750.0 shares were purchased.
